Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | CA4 | P22748 | 2/20 | 0.56 |
| ▸ | CA6 | P23280 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | CDK2 | P24941 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.50 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.50 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.50 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1803500 | 0.87 | TTR (0.68) | LDHACA2CA1CA9CA4 | |
| SCHEMBL532349 | 0.83 | TTR (0.48) | LDHACA2CA1CA9CA4 | |
| SCHEMBL150853 | 0.81 | TTR (0.78) | LDHATTRHDAC3IDO1EP300 | |
| SCHEMBL29516385 | 0.81 | TTR (0.78) | LDHATTRHDAC3IDO1EP300 | |
| SCHEMBL636440 | 0.81 | TTR (0.50) | LDHACA2CA1CA9CA4 | |
| SCHEMBL19922628 | 0.81 | TTR (0.50) | LDHACA2CA1CA9CA4 | |
| SCHEMBL1525888 | 0.81 | TTR (0.78) | LDHATTRHDAC3IDO1EP300 | |
| SCHEMBL10730555 | 0.81 | TTR (0.50) | LDHACA2CA1CA9CA4 | |
| SCHEMBL31603821 | 0.81 | TTR (0.50) | LDHATTRHDAC3IDO1EP300 | |
| SCHEMBL38143 | 0.81 | TTR (0.50) | LDHACA2CA1CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1014 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164252-A1 | ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-31 | — | — | WO | claimed |
| CN-105940083-B | Light wavelength conversion element containing ionic liquid and the article comprising the light wavelength conversion element | 日本化药株式会社 | 2019-06-11 | — | — | CN | claimed |
| CN-109342381-A | A kind of fluorescent dyeing reagent | 广州往圣生物科技有限公司 | 2019-02-15 | — | — | CN | claimed |
| US-9915665-B2 | High-throughput system and method for identifying antibodies having specific antigen binding activities | ABBVIE INC. (US) | 2018-03-13 | — | — | US | claimed |
| US-9546247-B2 | Explosive detection polymer comprising functionalized polyamine polymers and methods of using the same | UNIVERSITY OF CONNECTICUT (US) | 2017-01-17 | — | — | US | claimed |
| US-20160245757-A1 | A Method of Controlling Hydrophobic Contaminants by Utilizing a Fluorescent Dye | ECOLAB USA INC. (US) | 2016-08-25 | — | — | US | claimed |
| EP-3049807-A1 | A METHOD OF CONTROLLING HYDROPHOBIC CONTAMINANTS BY UTILIZING A FLUORESCENT DYE | Ecolab USA Inc. (US) | 2016-08-03 | — | — | EP | claimed |
| EP-2938636-A2 | HIGH-THROUGHPUT SYSTEM AND METHOD FOR IDENTIFYING ANTIBODIES HAVING SPECIFIC ANTIGEN BINDING ACTIVITIES | AbbVie Inc. (US) | 2015-11-04 | — | — | EP | claimed |
| WO-2015048241-A1 | A METHOD OF CONTROLLING HYDROPHOBIC CONTAMINANTS BY UTILIZING A FLUORESCENT DYE | ECOLAB USA INC. (US) | 2015-04-02 | — | — | WO | claimed |
| US-20150056711-A1 | Explosive Detection Polymer Comprising Functionalized Polyamine Polymers and Methods of Using the Same | UNIVERSITY OF CONNECTICUT (US) | 2015-02-26 | — | — | US | claimed |
| US-20140243228-A1 | HIGH-THROUGHPUT SYSTEM AND METHOD FOR IDENTIFYING ANTIBODIES HAVING SPECIFIC ANTIGEN BINDING ACTIVITIES | ABBVIE, INC. (US) | 2014-08-28 | — | — | US | claimed |
| WO-2014106004-A2 | HIGH-THROUGHPUT SYSTEM AND METHOD FOR IDENTIFYING ANTIBODIES HAVING SPECIFIC ANTIGEN BINDING ACTIVITIES | ABBVIE, INC. (US) | 2014-07-03 | — | — | WO | claimed |
| WO-2013165625-A2 | EXPLOSIVES DETECTION POLYMER COMPRISING FUNCTIONALIZED POLYAMINE POLYMERS AND METHODS OF USING THE SAME | UNIVERSITY OF CONNECTICUT (US) | 2013-11-07 | — | — | WO | claimed |
| WO-2013070943-A2 | SMALL MOLECULE SCREEN FOR INHIBITORS OF NFAT:AP-1:DNA INTERACTIONS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2013-05-16 | — | — | WO | claimed |
| WO-2026107198-A1 | ANTIBODY BIOMARKER TO DIAGNOSE IDIOPATHIC INFLAMMATORY MYOPATHIES | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4739790-A1 | METHODS AND COMPOSITIONS FOR STABILIZING CONCATEMERS | Pacific Biosciences of California, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260125675-A1 | DOWNREGULATING TROLLS USING NOVEL ANTISENSE OLIGONUCLEOTIDES TO OVERCOME RESISTANCE TO CHEMOTHERAPY | H LEE MOFFITT CANCER CENTER AND RESEARCH INST INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-4001253-A | NAPHTHOLACTAM DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-04 | — | — | US | disclosed |
| US-3978037-A | POLYAMIDES | CIBA-GEIGY CORPORATION (US) | 1976-08-31 | — | — | US | disclosed |
| US-3950347-A | NAPHTHOLACTAM DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125675-A1 | DOWNREGULATING TROLLS USING NOVEL ANTISENSE OLIGONUCLEOTIDES TO OVERCOME RESISTANCE TO CHEMOTHERAPY | PDCD1LG2, TRMT1L, TTLL12 | LDHA 2661/4885CA2 3352/4885CA1 2983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.